Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
73.9 USD | -1.15% | +0.64% | -7.15% |
Jun. 05 | Axsome Therapeutics Says It Settled Sunosi Patent Litigation With Unichem Laboratories | MT |
Jun. 05 | RBC Raises Price Target on Axsome Therapeutics to $130 From $127, Keeps Outperform Rating | MT |
Financials (USD)
Sales 2024 * | 376M | Sales 2025 * | 671M | Capitalization | 3.51B |
---|---|---|---|---|---|
Net income 2024 * | -233M | Net income 2025 * | -16M | EV / Sales 2024 * | 9.21 x |
Net cash position 2024 * | 46.33M | Net cash position 2025 * | 72.22M | EV / Sales 2025 * | 5.12 x |
P/E ratio 2024 * |
-15.2
x | P/E ratio 2025 * |
-327
x | Employees | 569 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 80.63% |
Latest transcript on Axsome Therapeutics, Inc.
1 day | -1.15% | ||
1 week | +0.64% | ||
Current month | +0.64% | ||
1 month | -2.35% | ||
3 months | -0.03% | ||
6 months | +5.30% | ||
Current year | -7.15% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 55 | 12-01-11 | |
Nick Pizzie
DFI | Director of Finance/CFO | 49 | 18-05-15 |
Mark Jacobson
COO | Chief Operating Officer | 40 | 14-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Saad
BRD | Director/Board Member | 54 | 14-11-30 |
Susan Mahony
BRD | Director/Board Member | 59 | 23-10-10 |
Roger Jeffs
BRD | Director/Board Member | 62 | 14-11-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.26% | 0 M€ | 0.00% | - | |
0.14% | 248 M€ | +11.05% | - | |
0.14% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 73.9 | -1.15% | 481,794 |
24-06-06 | 74.76 | +0.90% | 332,013 |
24-06-05 | 74.09 | +2.56% | 652,133 |
24-06-04 | 72.24 | -3.34% | 837,619 |
24-06-03 | 74.74 | +1.78% | 718,547 |
Delayed Quote Nasdaq, June 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.15% | 3.51B | |
+0.82% | 91.94B | |
-1.32% | 38.74B | |
-12.88% | 32.82B | |
+64.77% | 26.66B | |
-16.31% | 15.32B | |
-11.38% | 11.65B | |
+173.10% | 10.37B | |
-49.84% | 10.12B | |
+5.24% | 9.06B |
- Stock Market
- Equities
- AXSM Stock